Our objective is to define the initial, intracellular events of glucocorticoid hormone and steroid hormone action in general. Such studies are relevant since steroid receptors are arguably the best understood regulators of eukaryotic gene transcription. A major unresolved issue in steroid hormone action is what controls the activity of a given ligand bound to its cognate, intracellular receptor. One hypothesis is that ligand-induced conformational changes in the C-terminus of receptors, as revealed by partial proteolysis, might determine the agonist vs antagonist activity of the receptor-steroid complex. We have found that steroid binding does cause a conformational change in glucocorticoid receptors (GRs), as detected by partial trypsin digestion. However, no uniformity of digestion patterns was found for unactivated or activated receptors bound with a series of six structurally different antagonists. Using a series of point mutations and epitope-specific antibodies, it was determined that the various tryptic fragments arose from C-terminal and/or internal cleavages. Thus, the presence or absence of C-terminal amino acids of the GR did not uniquely determine either the appearance of smaller trypsin-resistant fragments or the nature of the biological response of receptor-bound antisteroids. An unusual parameter that has been described to influence the activity of GR complexes is a 21 bp sequence, located at -3.6 kb of the rat tyrosine aminotransferase (TAT) gene, which causes both a left shift in the dose-response curve of agonists and an increase the partial agonist activity of antagonists. Because this behaviour is seen both with the endogenous TAT gene and synthetic reporter genes, the 21 bp element has been called a glucocorticoid modulatory element, or GME. We have now characterized the neighboring TAT gene sequences and find that two other elements cooperate with the GME to afford the full activity of the native gene: a negative element at -3.1 kb and a neutralizing sequence between -2.6 and -2.3 kb. Such a grouping of elements appears to be novel among steroid regulated genes but is a not uncommon in other systems. The activities of this complex grouping can be reproduced by constructs containing just the GME and synthetic promoter and reporters, thereby simplifying future studies with the two GME binding proteins that we have recently cloned. Collectively, our findings contribute to our long term goal of defining the action of steroid hormones at a molecular level and of understanding their role in human physiology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK057800-06
Application #
6162040
Study Section
Special Emphasis Panel (LMCB)
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1997
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Ronacher, Katharina; Hadley, Katie; Avenant, Chanel et al. (2009) Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction. Mol Cell Endocrinol 299:219-31
Tao, Yong-guang; Xu, Yong; Xu, H Eric et al. (2008) Mutations of glucocorticoid receptor differentially affect AF2 domain activity in a steroid-selective manner to alter the potency and efficacy of gene induction and repression. Biochemistry 47:7648-62
Simons Jr, S Stoney (2008) What goes on behind closed doors: physiological versus pharmacological steroid hormone actions. Bioessays 30:744-56
Suino-Powell, Kelly; Xu, Yong; Zhang, Chenghai et al. (2008) Doubling the size of the glucocorticoid receptor ligand binding pocket by deacylcortivazol. Mol Cell Biol 28:1915-23
Wang, Dongqing; Wang, Qi; Awasthi, Smita et al. (2007) Amino-terminal domain of TIF2 is involved in competing for corepressor binding to glucocorticoid and progesterone receptors. Biochemistry 46:8036-49
Simons Jr, S Stoney (2006) How much is enough? Modulation of dose-response curve for steroid receptor-regulated gene expression by changing concentrations of transcription factor. Curr Top Med Chem 6:271-85
Kim, Yuli; Sun, Yunguang; Chow, Carson et al. (2006) Effects of acetylation, polymerase phosphorylation, and DNA unwinding in glucocorticoid receptor transactivation. J Steroid Biochem Mol Biol 100:3-17
Cho, Sehyung; Kagan, Benjamin L; Blackford Jr, John A et al. (2005) Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9. Mol Endocrinol 19:290-311
Cho, Sehyung; Blackford Jr, John A; Simons Jr, S Stoney (2005) Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes. Biochemistry 44:3547-61
Wang, Dongqing; Simons Jr, S Stoney (2005) Corepressor binding to progesterone and glucocorticoid receptors involves the activation function-1 domain and is inhibited by molybdate. Mol Endocrinol 19:1483-500

Showing the most recent 10 out of 31 publications